Eduardo Richardet, MD, PhD | Authors

Uracil/Tegafur Plus Oral Calcium Folinate in Advanced Breast Cancer

July 01, 1999

Uracil and tegafur (in a molar ratio of 4:1 [UFT]) has proven activity against breast cancer and is delivered in an easy-to-administer oral formulation. Orzel, which combines UFT with the oral biomodulator, calcium folinate, may